# Transverse Abdominus Plane Block Study

> **NCT05216055** · PHASE2 · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- Colorectal Disorders
- Surgery

## Interventions

- **COMBINATION_PRODUCT:** Ropivacaine, Dexmedetomidine, Dexamethasone sodium phosphate, Normal saline
- **DRUG:** Liposomal bupivacaine

## Key facts

- **NCT ID:** NCT05216055
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-04-19
- **Primary completion:** 2022-12-16
- **Final completion:** 2022-12-27
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No Accrual. PI left Institution
- **Last updated:** 2023-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05216055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05216055, "Transverse Abdominus Plane Block Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05216055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*